Skip to Main Content
Phase III

Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)

  • Study HIC#:2000027269
  • Last Updated:11/15/2022

PACeS is a trial to study most effective treatment for patients who may experience atrial fibrillation after cardiac surgery, particularly coronary artery bypass grafting (CABG). Atrial fibrillation, or Afib (AF), is an irregular heart rhythm. In some cases, AF can cause blood clots. There are currently 2 classes of drugs for preventing blood clots in patients with AF. Antiplatelets, like aspirin, and anticoagulants, or blood thinners. This study aims to determine whether the addition of blood thinners to antiplatelets will improve treatment outcomes in patients who develop AF after CABG.

  • Age18 years and older
  • GenderBoth
  • Start Date03/01/2021
  • End Date12/31/2022

Eligibility Criteria

Eligibility Criteria:

Any patient over 18 years of age who experiences a post-CABG episode of AF.

Principal Investigator

For more information about this study, contact:

Or contact the Help us Discover team on: